Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
about
Involvement of DNA damage response pathways in hepatocellular carcinoma.Alternative splicing of FBP-interacting repressor coordinates c-Myc, P27Kip1/cyclinE and Ku86/XRCC5 expression as a molecular sensor for bleomycin-induced DNA damage pathway.Attenuation of krüppel-like factor 4 facilitates carcinogenesis by inducing g1/s phase arrest in clear cell renal cell carcinomaImpact of the Ku complex on HIV-1 expression and latency.By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.Connexin32 regulates hepatoma cell metastasis and proliferation via the p53 and Akt pathways.MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinomaRETRACTED: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.Ku80 correlates with neoadjuvant chemotherapy resistance in human lung adenocarcinoma, but reduces cisplatin/pemetrexed-induced apoptosis in A549 cells.Splenectomy suppresses growth and metastasis of hepatocellular carcinoma through decreasing myeloid-derived suppressor cells in vivo.Smad6 suppresses the growth and self-renewal of hepatic progenitor cells.Small Molecules, Inhibitors of DNA-PK, Targeting DNA Repair, and Beyond.Epigenetic repression of Krüppel-like factor 4 through Dnmt1 contributes to EMT in renal fibrosis.Functional analysis of the new barley gene HvKu80 indicates that it plays a key role in double-strand DNA break repair and telomere length regulation.Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice.Vorinostat enhances the anticancer effect of oxaliplatin on hepatocellular carcinoma cells.Suberoylanilide hydroxamic acid enhances chemosensitivity to 5-fluorouracil in hepatocellular carcinoma via inhibition of thymidylate synthase.18β-Glycyrrhetinic-acid-mediated unfolded protein response induces autophagy and apoptosis in hepatocellular carcinoma.Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer
P2860
Q33616812-F361C1A6-2DBF-4B66-BDF7-8D48F1359E1DQ33757013-96FE6777-A773-46B6-BFCD-B693E12C0FCBQ34826101-752826AB-A39D-4F7A-BCFC-2CE2277F6A62Q34903532-3211D879-D80E-40CA-BD3E-4799B8A14F1DQ35176335-FDDF99FF-2EC2-4F6F-A768-46B90C17B414Q35832932-0F648D50-C5C1-4292-B34F-42B4D91E2F70Q37225640-953BF65F-E364-4A9B-A119-25260C5AAC29Q37330849-BFFB98B8-82D4-489C-8776-BF176BDCBF18Q37747947-6C38CDF9-7FBC-4FED-A8CA-CB7F72294AFCQ38740336-150080CD-2954-44CF-AA1B-CCF3576CD652Q39032523-C2A5C4F0-B90D-433E-90EA-4FE523B39106Q39471754-246E7105-6DC6-4B34-A944-D215E766FA59Q40701780-79C263D4-06F3-4ED0-BC0A-AF36D7869224Q40956429-05AC6302-196D-48EB-8FD8-7D80FC96A6EDQ43771802-C4EDE92F-7B8E-44AC-BA67-289E763D8B0EQ48119543-49B89750-B8F8-47EB-A7C9-2B5C453ACB2AQ52935211-3BE48B54-67B6-4BC5-880F-524D63DD9F5AQ55367835-0EA034AE-4377-48F9-B5C5-157AE3A8D742Q58741539-33A42DE6-4E17-4978-87A8-3804E4B618FC
P2860
Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Ku80 functions as a tumor supp ...... rough a p53-dependent pathway.
@en
Ku80 functions as a tumor supp ...... rough a p53-dependent pathway.
@nl
type
label
Ku80 functions as a tumor supp ...... rough a p53-dependent pathway.
@en
Ku80 functions as a tumor supp ...... rough a p53-dependent pathway.
@nl
prefLabel
Ku80 functions as a tumor supp ...... rough a p53-dependent pathway.
@en
Ku80 functions as a tumor supp ...... rough a p53-dependent pathway.
@nl
P2093
P2860
P356
P1433
P1476
Ku80 functions as a tumor supp ...... hrough a p53-dependent pathway
@en
P2093
Bin-yong Liang
Da-qian Zhan
Shuang Wei
Xiao-ping Chen
Yang-yang Wang
Zhi-yong Huang
P2860
P304
P356
10.1093/CARCIN/BGR319
P407
P577
2012-01-05T00:00:00Z